DERM
Journey Medical Corp
Key Financials
Operating Income
$-8172000
↑ 40.3%
Revenue
$61.9M
↑ 10.2%
Net Income
$-11431000
↑ 22.1%
EPS (Diluted)
$-0.47
↑ 34.7%
Total Assets
$94.6M
↑ 17.9%
Cash & Equivalents
$24.1M
↑ 18.6%
Total Liabilities
$62.7M
↑ 4.3%
Shareholders' Equity
$31.9M
↑ 58.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 4/6/2026 | View on SEC |
| 10-K | 3/26/2026 | View on SEC |
| 8-K | 3/25/2026 | View on SEC |
| 424B3 | 1/23/2026 | View on SEC |
| 424B3 | 1/23/2026 | View on SEC |
| EFFECT | 1/21/2026 | View on SEC |
| S-3 | 1/15/2026 | View on SEC |
| DRS | 12/30/2025 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| 8-K | 11/12/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DERM |
| Company Name | Journey Medical Corp |
| CIK | 1867066 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 480-434-6670 |